• Je něco špatně v tomto záznamu ?

Glucagon-like peptide-1 analogues exenatide and liraglutide exert inhibitory effect on the early phase of liver regeneration after partial hepatectomy in rats

J. Fontana, O. Kučera, V. Mezera, M. Anděl, Z. Červinková

. 2017 ; 66 (5) : 833-844. [pub] 20170718

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18026979

Glucagon-like peptide-1 (GLP-1) is an incretin known for proliferative and antiapoptotic effects on various tissues. Exenatide and Liraglutide are GLP-1 analogues used in clinical practice as antidiabetic drugs. Since GLP-1 and its analogues exert significant effect on liver metabolism and since changes in intermediary metabolism play an important role in the process of liver regeneration, we decided to determine the effect of Exenatide and Liraglutide on the early phase of liver regeneration and selected metabolic parameters in a model of 2/3 partial hepatectomy (PHx) in rats. Animals were submitted either to PHx or laparotomy and received 3 doses of either GLP-1 analogues (Exenatide - 42 microg/kg b.w., Liraglutide - 0.75 mg/kg b.w.) or saline intraperitoneally. We analyzed body and liver weight, liver bromodeoxyuridine incorporation, liver content of DNA, triacylglycerols and cholesterol and biochemical serum parameters. Bromodeoxyuridine labeling was significantly lower in hepatectomized rats receiving either type of GLP-1 analogues when compared to hepatectomized controls. This effect was more pronounced in the Liraglutide group compared to Exenatide (p<0.001). In addition, liver DNA content was lower in hepatectomized rats receiving Liraglutide than in hepatectomized control rats (p<0.001). In conclusion, GLP-1 analogues Exenatide and Liraglutide significantly inhibited an early phase of liver regeneration after PHx in rats. This inhibitory effect was more pronounced in rats receiving Liraglutide.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18026979
003      
CZ-PrNML
005      
20200429073942.0
007      
ta
008      
180730s2017 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933464 $2 doi
035    __
$a (PubMed)28730824
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Fontana, Josef $u Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0256883
245    10
$a Glucagon-like peptide-1 analogues exenatide and liraglutide exert inhibitory effect on the early phase of liver regeneration after partial hepatectomy in rats / $c J. Fontana, O. Kučera, V. Mezera, M. Anděl, Z. Červinková
520    9_
$a Glucagon-like peptide-1 (GLP-1) is an incretin known for proliferative and antiapoptotic effects on various tissues. Exenatide and Liraglutide are GLP-1 analogues used in clinical practice as antidiabetic drugs. Since GLP-1 and its analogues exert significant effect on liver metabolism and since changes in intermediary metabolism play an important role in the process of liver regeneration, we decided to determine the effect of Exenatide and Liraglutide on the early phase of liver regeneration and selected metabolic parameters in a model of 2/3 partial hepatectomy (PHx) in rats. Animals were submitted either to PHx or laparotomy and received 3 doses of either GLP-1 analogues (Exenatide - 42 microg/kg b.w., Liraglutide - 0.75 mg/kg b.w.) or saline intraperitoneally. We analyzed body and liver weight, liver bromodeoxyuridine incorporation, liver content of DNA, triacylglycerols and cholesterol and biochemical serum parameters. Bromodeoxyuridine labeling was significantly lower in hepatectomized rats receiving either type of GLP-1 analogues when compared to hepatectomized controls. This effect was more pronounced in the Liraglutide group compared to Exenatide (p<0.001). In addition, liver DNA content was lower in hepatectomized rats receiving Liraglutide than in hepatectomized control rats (p<0.001). In conclusion, GLP-1 analogues Exenatide and Liraglutide significantly inhibited an early phase of liver regeneration after PHx in rats. This inhibitory effect was more pronounced in rats receiving Liraglutide.
650    _2
$a zvířata $7 D000818
650    _2
$a glukagonu podobný peptid 1 $x analogy a deriváty $7 D052216
650    _2
$a hepatektomie $x trendy $7 D006498
650    _2
$a liraglutid $x farmakologie $7 D000069450
650    _2
$a regenerace jater $x účinky léků $x fyziologie $7 D008115
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a peptidy $x farmakologie $7 D010455
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a živočišné jedy $x farmakologie $7 D014688
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kučera, Otto, $d 1977- $7 xx0041536 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic
700    1_
$a Mezera, Vojtěch $7 xx0231137 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic
700    1_
$a Andělová, Michaela $7 xx0269345 $u Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Červinková, Zuzana, $d 1951- $7 nlk20020106444 $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 5 (2017), s. 833-844
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28730824 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20180730 $b ABA008
991    __
$a 20200429073936 $b ABA008
999    __
$a ok $b bmc $g 1326190 $s 1023911
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 66 $c 5 $d 833-844 $e 20170718 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20180730

Najít záznam

Citační ukazatele

Možnosti archivace